NeuroMetrix, Inc. (NURO)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Shai N. Gozani M.D., Ph.D. | Founder, Chairman, CEO, President & Secretary | 444.05k | -- | 1965 |
Mr. Thomas T. Higgins | Senior VP, CFO & Treasurer | 347.75k | -- | 1952 |
Dr. Xuan Kong Ph.D. | Chief Data Scientist | -- | -- | -- |
Ms. Susan M. Bell R.N. | Senior Vice President of Population Health & Value Based Care | -- | -- | -- |
NeuroMetrix, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 26
Description
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Corporate Governance
Recent Events
- Apr 19, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Apr 12, 2024DEFA14A: Proxy StatementsSee Full Filing
- Apr 05, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Mar 27, 2024DEF 14A: Proxy StatementsSee Full Filing
- Mar 01, 202410-K: Periodic Financial ReportsSee Full Filing